India, May 31 -- As global geopolitical tensions continue to rise, ensuring resilience in interconnected systems ...

China's booming pharmaceutical industry is not being impacted by Beijing's ‌tightening scrutiny over deals involving ...

The pharmaceutical contract manufacturing market is driven by increased outsourcing of complex processes to CMOs, enabling ...

The US pharmaceutical industry expressed support for the US Food and Drug Administration’s (FDA) proposed framework for increasing access to treatments for ultra-rare diseases yet raised questions ...

Manufacturing deals saw an unusual burst of recent activity, with a spike in the number of CDMOs acquiring facilities from pharma companies.

Residues of pharmaceutical products can enter the environment during the manufacturing process, during usage, and disposal. With the growing trend in sustainable practices, the translation of ...

In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...

The development would create nearly 500 jobs.

A visitor looks at the introduction of medicines for vaccines and chronic diseases at the Sanofi booth at the 5th CIIE in ...

Procurement frameworks now incorporate resilience criteria, enabling tender preference for diversified, Europe-based manufacturing and contingency capacity over lowest price, reshaping economics for ...

AstraZeneca's Clean Heat Program is turning industrial heat decarbonization into a hedge against energy volatility — and a ...